Drug manufacturer Eli Lilly & Co. will pay $18.5 million to shut down Mississippi's case against it for promotional claims related to the anti-psychotic drug, Zyprexa.
The consent judgment was filed in Circuit Court of Lafayette County earlier this week.
Lilly also agrees to curb marketing activities and payment to health care professionals in its promotion of the drug, approved for treatment of bipolar disorders.
In the 23-page settlement, the company does not admit it's violated any state consumer protection laws and says it has not committed any "liability, fault or wrongdoing."
The agreement with the Attorney General's Office does not protect Lilly from criminal allegations.
The settlement, approved by Judge Andrew Howorth, especially aims at curbing Lilly's activities related to non-approved uses of the drug.